HEPA · Hepion Pharmaceuticals, Inc. · Insider Trading

Warrant is only exercisable upon stockholder approval of an increase in the authorized shares of the Company's Common Stock.

Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.

336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.

336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.

336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.

336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.

Mr. LoPriore is the trustee and beneficiary of the Invictus Capital Advisors Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity.

Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.

Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.

Mr. LoPriore is the trustee and beneficiary of the Invictus Capital Advisors Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity.

Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.

Through Stetz Belgiovine CPA 401K F/B/O Gary S. Stetz

Mr. LoPriore is the trustee and beneficiary of the Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity.

The Reporting Person was granted restricted stock units (RSU's) which represent a contingent right to receive one share of Common Stock for each RSU.

Upon the earlier of (i) one year from date of grant or (ii) a change of control of the Issuer.

Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.

Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.

Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.

Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.

400,000 of the stock options vest on 5/18/2022 and the remainder vests monthly in equal amounts over 24 months.

Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.

Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.

Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.

Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.

633,333 of the stock options vest on 5/18/2022 and the remainder vests monthly in equal amounts over 24 months.